These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 38243954)

  • 1. Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus.
    Al-Busaidi A; Alabri O; Alomairi J; ElSharaawy A; Al Lawati A; Al Lawati H; Das S
    Curr Diabetes Rev; 2024; 21(1):e170124225723. PubMed ID: 38243954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota and Complications of Type-2 Diabetes.
    Iatcu CO; Steen A; Covasa M
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut dysbiosis contributes to SCFAs reduction-associated adipose tissue macrophage polarization in gestational diabetes mellitus.
    Li H; Liu S; Chen H; Zhou L; Chen B; Wang M; Zhang D; Han TL; Zhang H
    Life Sci; 2024 Aug; 350():122744. PubMed ID: 38810793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota and Their Associated Metabolites in Diabetes: A Cross Talk Between Host and Microbes-A Review.
    Safari-Alighiarloo N; Emami Z; Rezaei-Tavirani M; Alaei-Shahmiri F; Razavi S
    Metab Syndr Relat Disord; 2023 Feb; 21(1):3-15. PubMed ID: 36301254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the gut microbiota-adipose tissue-muscle interactions by prebiotics.
    Rodriguez J; Delzenne NM
    J Endocrinol; 2021 Apr; 249(1):R1-R23. PubMed ID: 33502337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota dysbiosis -associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review.
    Hamjane N; Mechita MB; Nourouti NG; Barakat A
    Microvasc Res; 2024 Jan; 151():104601. PubMed ID: 37690507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-37 sensitize the elderly type 2 diabetic patients to insulin therapy through suppressing the gut microbiota dysbiosis.
    Li T; Li H; Li W; Chen S; Feng T; Jiao W; Wu C; Dong J; Li Y; Li S; Feng M; Wei X
    Mol Immunol; 2019 Aug; 112():322-329. PubMed ID: 31238287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
    Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
    J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The underlying causes, treatment options of gut microbiota and food habits in type 2 diabetes mellitus: a narrative review.
    Adhikary K; Sarkar R; Maity S; Banerjee I; Chatterjee P; Bhattacharya K; Ahuja D; Sinha NK; Maiti R
    J Basic Clin Physiol Pharmacol; 2024 May; 35(3):153-168. PubMed ID: 38748886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the microbiome in the management of children with type 2 diabetes mellitus.
    Brar PC; Kohn B
    Curr Opin Pediatr; 2019 Aug; 31(4):524-530. PubMed ID: 31299021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE INTESTINAL MICROBIOME IN PATIENTS UNDERGOING BARIATRIC SURGERY: A SYSTEMATIC REVIEW.
    Gentile JKA; Oliveira KD; Pereira JG; Tanaka DY; Guidini GN; Cadona MZ; Siriani-Ribeiro DW; Perondini MT
    Arq Bras Cir Dig; 2022; 35():e1707. PubMed ID: 36542005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
    Duan L; An X; Zhang Y; Jin D; Zhao S; Zhou R; Duan Y; Zhang Y; Liu X; Lian F
    Biomed Pharmacother; 2021 Oct; 142():112094. PubMed ID: 34449321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications.
    Ortega MA; Fraile-Martínez O; Naya I; García-Honduvilla N; Álvarez-Mon M; Buján J; Asúnsolo Á; de la Torre B
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32917030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice.
    Bagarolli RA; Tobar N; Oliveira AG; Araújo TG; Carvalho BM; Rocha GZ; Vecina JF; Calisto K; Guadagnini D; Prada PO; Santos A; Saad STO; Saad MJA
    J Nutr Biochem; 2017 Dec; 50():16-25. PubMed ID: 28968517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiome Changes in Gestational Diabetes.
    Ionescu RF; Enache RM; Cretoiu SM; Gaspar BS
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.